Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.27EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.27EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.71EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.71ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.71ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.71EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.71EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.71ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.12.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.12.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.12.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.12.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.12.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.12.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.12.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.12.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.1.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DN.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DN.1.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DN.1.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DN.1.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DN.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DN.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.122EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.122EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.122ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.122ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.122EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.122EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.122ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.122ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAJEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XAJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAJECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XAJECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XAJEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XAJEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XAJENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAJENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.431EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.431EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.431ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.431ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.431EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.431EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used